Pharmacy

Long periods of market exclusivity are no longer needed with technology that allows for faster, safer drug development, Jonathan Kimball, vice president for trade and international affairs at the Association for Accessible Medicines, argued in an opinion piece published in…

Walmart is joining CVS, Walgreens and Rite Aid in temporarily halting sales of Zantac and other ranitidine products after the FDA flagged a possible carcinogen in the heartburn drugs.

Teva Pharmaceutical Industries' executive vice president of global operations Carlo de Notaristefani, PhD, stepped down Oct. 2.

Rep. Lloyd Doggett, D-Texas, is circulating a letter around Congress calling for changes to House Speaker Nancy Pelosi's drug-pricing bill that was introduced last month.

Japan-based NS Pharma filed for FDA approval Oct. 2 for its Duchenne muscular dystrophy treatment, dealing another blow to Sarepta, whose Duchenne drug was rejected by the FDA in August.

Not only are gene therapies expensive, they are physically out of reach for many patients, according to a PwC Health Research Institute report.

Civica Rx's first medication was given to patients at a Utah hospital Oct. 2.

Johnson & Johnson has agreed to pay $20.4 million to avoid the first federal trial that accuses the drugmaker of fueling the opioid epidemic.

Compared to small chain pharmacies, retail pharmacy giants like CVS Pharmacy and Walgreens offered the lowest cash price for generic drugs according to data published Oct. 1.

Mallinckrodt changed its severance package policy in a move that could indicate it's preparing for a change in ownership structure, according to The Wall Street Journal.